{"blog": [], "keywords": [{"value": "Drugs (Pharmaceuticals)", "name": "subject", "rank": "1", "is_major": "Y"}, {"value": "Food and Drug Administration", "name": "organizations", "rank": "2", "is_major": "Y"}, {"value": "Government Accountability Office", "name": "organizations", "rank": "3", "is_major": "Y"}, {"value": "House of Representatives", "name": "organizations", "rank": "4", "is_major": "N"}], "web_url": "http://www.nytimes.com/2016/01/15/health/fda-faulted-for-problems-with-drug-tracking.html", "document_type": "article", "byline": {"person": [{"lastname": "TAVERNISE", "firstname": "Sabrina", "role": "reported", "organization": "", "rank": 1}], "original": "By SABRINA TAVERNISE"}, "type_of_material": "News", "multimedia": [{"url": "images/2016/01/15/science/15FDA/15FDA-thumbWide.jpg", "legacy": {"wide": "images/2016/01/15/science/15FDA/15FDA-thumbWide.jpg", "wideheight": "126", "widewidth": "190"}, "subtype": "wide", "type": "image", "width": 190, "height": 126}, {"url": "images/2016/01/15/science/15FDA/15FDA-articleLarge.jpg", "legacy": {"xlarge": "images/2016/01/15/science/15FDA/15FDA-articleLarge.jpg", "xlargeheight": "364", "xlargewidth": "600"}, "subtype": "xlarge", "type": "image", "width": 600, "height": 364}, {"url": "images/2016/01/15/science/15FDA/15FDA-thumbStandard.jpg", "legacy": {"thumbnail": "images/2016/01/15/science/15FDA/15FDA-thumbStandard.jpg", "thumbnailheight": "75", "thumbnailwidth": "75"}, "subtype": "thumbnail", "type": "image", "width": 75, "height": 75}], "section_name": "Health", "word_count": "532", "source": "The New York Times", "subsection_name": null, "lead_paragraph": "The system the Food and Drug Administration uses to keep data on drugs after they have come to market is incomplete, outdated and often inaccurate, federal investigators said.", "pub_date": "2016-01-15T00:00:00Z", "news_desk": "National", "headline": {"print_headline": "F.D.A. Faulted on Tracking Drug Problems", "main": "F.D.A. Faulted for Problems With Drug Tracking"}, "print_page": "22", "snippet": "The system the Food and Drug Administration uses to keep data on drugs after they have come to market is incomplete, outdated and often inaccurate, federal investigators said.", "_id": "56981f5b38f0d8108a7eb759", "slideshow_credits": null, "abstract": "Government Accountability Office report finds Food and Drug Administration has flaws in process it uses to track drugs after they go on market, which raises concerns about agency's efficacy as main drug overseer in country."}